Get the Stockscreener App
1.21
7.28%
-0.095
After Hours:
1.25
0.04
+3.31%
Painreform Ltd stock is traded at $1.21, with a volume of 489.52K.
It is down -7.28% in the last 24 hours and down -14.79% over the past month.
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.
See More
Previous Close:
$1.305
Open:
$1.3333
24h Volume:
489.52K
Relative Volume:
0.18
Market Cap:
$2.44M
Revenue:
-
Net Income/Loss:
$-9.34M
P/E Ratio:
-0.1695
EPS:
-7.14
Net Cash Flow:
$-6.69M
1W Performance:
-12.95%
1M Performance:
-14.79%
6M Performance:
-41.83%
1Y Performance:
-48.11%
1-Day Range:
$1.20
$1.38
1-Week Range:
$1.20
$1.4884
52-Week Range:
$1.20
$16.63
Painreform Ltd Stock (PRFX) Company Profile
Compare PRFX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRFX
Painreform Ltd
|
1.21 | 2.63M | 0 | -9.34M | -6.69M | -7.14 |
|
ZTS
Zoetis Inc
|
142.26 | 62.54B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.72 | 43.30B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.08 | 40.08B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.02 | 22.98B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
440.06 | 19.90B | 3.08B | 1.24B | 1.07B | 25.61 |
Painreform Ltd Stock (PRFX) Latest News
Should you wait for a breakout in PainReform Ltd.Earnings Risk Report & AI Enhanced Trading Alerts - newser.com
Is PainReform Ltd. stock cheap at current valuationJuly 2025 Earnings & Reliable Volume Spike Alerts - newser.com
Historical volatility pattern of PainReform Ltd. visualized2025 Momentum Check & Free Fast Entry Momentum Trade Alerts - newser.com
Is PainReform Ltd. building a consolidation baseJuly 2025 Decliners & Community Trade Idea Sharing Platform - newser.com
Risk vs reward if holding onto PainReform Ltd.Weekly Trading Summary & Expert Verified Movement Alerts - newser.com
Applying sector rotation models to PainReform Ltd.Trade Performance Summary & Growth Focused Stock Pick Reports - newser.com
Chart based analysis of PainReform Ltd. trendsShare Buyback & Growth Focused Stock Reports - newser.com
Chart overlay techniques for tracking PainReform Ltd.Quarterly Performance Summary & Long-Term Safe Return Strategies - newser.com
Will PainReform Ltd. outperform the marketWeekly Trade Report & AI Enhanced Trade Execution Alerts - newser.com
What momentum shifts mean for PainReform Ltd.Market Performance Summary & Capital Protection Trading Alerts - newser.com
Can machine learning forecast PainReform Ltd. recoveryJuly 2025 News Drivers & Expert-Curated Trade Recommendations - newser.com
Pattern recognition hints at PainReform Ltd. upsideQuarterly Earnings Report & Long Hold Capital Preservation Plans - newser.com
PainReform Announces H1 2025 Financial Results and Board Change - MSN
Should you hold or exit PainReform Ltd. nowMarket Volume Summary & Free Verified High Yield Trade Plans - newser.com
Wall Street Zen Upgrades PainReform (NASDAQ:PRFX) to “Hold” - Defense World
PainReform reports mixed progress in pharma and solar tech ventures By Investing.com - Investing.com Nigeria
PainReform Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025 - MarketScreener
Painreform provides business update for the six months ended June 30, 2025 - MarketScreener
Painreform Provides Business Update For The Six Months Ended June 30, 2025 - TradingView
PainReform (PRFX) Reports Transformative Developments in Pharmac - GuruFocus
PainReform reports mixed progress in pharma and solar tech ventures - Investing.com India
PainReform Ltd. Reports Business Update and Financial Results for First Half of 2025, Highlights Investment in LayerBio and Progress in Pharmaceutical and Smart Energy Divisions - Quiver Quantitative
PainReform Provides Business Update for the Six Months Ended June 30, 2025 - GlobeNewswire
$9B Market Opportunity: PainReform's New Dropless Cataract Therapy Could Transform Post-Surgery Care - Stock Titan
Is PainReform Ltd a good long term investmentMarket Correction Analysis & Rapid Profit Portfolio - earlytimes.in
What drives PainReform Ltd stock priceAnalyst Downgrades & Create Your Free Watchlist Instantly - Early Times
What analysts say about PainReform Ltd stockPrice Channel Trading & Free Turn Volatility To Profit - Early Times
Will PainReform Ltd. stock sustain high P E ratiosJuly 2025 Trends & Weekly Watchlist for Consistent Profits - The British Mountaineering Council
PainReform Enters Cataract Surgery Market with LayerBio Investment - MSN
PainReform Ltd. stock prediction for this weekQuarterly Earnings Report & Real-Time Volume Trigger Notifications - newser.com
PainReform (NASDAQ:PRFX) Cut to “Strong Sell” at Wall Street Zen - Defense World
Published on: 2025-09-20 23:16:59 - khodrobank.com
Technical signs of recovery in PainReform Ltd.Market Performance Report & Precise Buy Zone Tips - newser.com
Highs Report: Is PainReform Ltd stock a top performer YTD2025 Top Gainers & Technical Confirmation Alerts - خودرو بانک
How to interpret RSI for PainReform Ltd. stockVolume Spike & Verified Chart Pattern Signals - newser.com
Painreform Ltd Stock (PRFX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):